About Grove Biopharma
Grove Biopharma is a company based in Chicago (United States) founded in 2020 by Geoff Duyk and Paul A Bertin.. Grove Biopharma has raised $34 million across 3 funding rounds from investors including Lilly, Gradiant and HHS. Grove Biopharma offers products and services including Bionic Biologics. Grove Biopharma operates in a competitive market with competitors including Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.
- Headquarter Chicago, United States
- Founders Geoff Duyk, Paul A Bertin
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$34 M (USD)
in 3 rounds
-
Latest Funding Round
$30 M (USD), Series A
Apr 23, 2025
-
Investors
Lilly
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Grove Biopharma
Grove Biopharma offers a comprehensive portfolio of products and services, including Bionic Biologics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Synthetic biomolecules for targeting and disrupting intracellular proteins in diseases.
Unlock access to complete
Unlock access to complete
Funding Insights of Grove Biopharma
Grove Biopharma has successfully raised a total of $34M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $30 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $30.0M
-
First Round
First Round
(10 May 2021)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series A - Grove Biopharma | Valuation | DCVC | |
| Jul, 2023 | Amount | Grant - Grove Biopharma | Valuation |
investors |
|
| May, 2021 | Amount | Seed - Grove Biopharma | Valuation | Portal Innovations , Skydeck Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Grove Biopharma
Grove Biopharma has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Lilly, Gradiant and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
InVivium Capital is focused on healthcare and life sciences investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Grove Biopharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Grove Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Grove Biopharma Comparisons
Competitors of Grove Biopharma
Grove Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based protein-modeling software is developed for drug discovery.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
|
| domain | founded_year | HQ Location |
Small molecule oncology therapeutics are developed for cancer treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Grove Biopharma
When was Grove Biopharma founded?
Grove Biopharma was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Grove Biopharma located?
Grove Biopharma is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Is Grove Biopharma a funded company?
Grove Biopharma is a funded company, having raised a total of $34M across 3 funding rounds to date. The company's 1st funding round was a Seed of $4M, raised on May 10, 2021.
What does Grove Biopharma do?
Grove Biopharma was established in 2020 in Chicago, United States. Focus is placed on the biopharma sector, where an AI-based drug modality platform is developed to support protein-based therapeutics. Operations involve leveraging artificial intelligence for drug discovery and development processes. The company is co-founded by Geoff Duyk and Paul A. Bertin, with activities centered in the United States.
Who are the top competitors of Grove Biopharma?
Grove Biopharma's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Biognosys.
What products or services does Grove Biopharma offer?
Grove Biopharma offers Bionic Biologics.